IMMUNOHISTOCHEMISTRY, FSH

The IHC – FSH (Follicle Stimulating Hormone) test is an immunohistochemistry-based diagnostic assay used to detect FSH hormone expression in tissue samples. Follicle Stimulating Hormone is produced by specialized cells of the anterior pituitary gland and plays a crucial role in regulating reproductive function in both males and females.

This test is primarily used in pathology to identify and classify pituitary adenomas and other endocrine tumors that may produce FSH. By detecting hormone expression within tumor tissue, the test helps pathologists determine the functional status and cellular origin of pituitary neoplasms.

FSH-producing pituitary tumors are relatively uncommon but can be associated with hormonal imbalances and endocrine dysfunction. Immunohistochemical staining for FSH is an important component of comprehensive pituitary tumor evaluation and classification.

Benefits of the Test

• Helps diagnose FSH-producing pituitary adenomas
• Assists in pituitary tumor classification
• Supports endocrine tumor characterization
• Identifies hormone-producing tumor cells
• Helps guide treatment planning and patient management

Why Doctors Recommend This Test

Doctors recommend the IHC FSH test when evaluating pituitary gland tumors and endocrine neoplasms. It is commonly used in:

• Diagnosis of pituitary adenomas
• Classification of hormone-producing pituitary tumors
• Assessment of endocrine gland neoplasms
• Evaluation of sellar and suprasellar masses
• Investigation of pituitary hormone abnormalities

The test is frequently performed alongside other pituitary hormone markers such as LH, Prolactin, Growth Hormone (GH), ACTH, TSH, and Ki-67 for comprehensive tumor profiling.

Preparation Before Test

No special preparation is required for this test. Important considerations include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting is required
• No medication restrictions are usually necessary
• Hormonal laboratory results and imaging findings may assist interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on tissue processing requirements and laboratory workflow.

Who Should Take This Test

• Patients with suspected pituitary adenoma
• Individuals undergoing pituitary tumor surgery
• Patients with endocrine gland tumors
• Cases requiring pituitary tumor classification
• Oncology and endocrinology patients requiring hormone marker evaluation

The IHC FSH test is an important diagnostic tool in endocrine pathology. By identifying FSH-producing cells within tumors, it helps clinicians accurately classify pituitary neoplasms and develop appropriate treatment strategies.

Clinical Significance

FSH immunostaining is commonly used in the evaluation of:

• Pituitary adenomas
• Gonadotroph adenomas
• Functional pituitary tumors
• Non-functioning pituitary neoplasms
• Endocrine gland tumors
• Sellar region masses

The test helps determine whether tumor cells are producing Follicle Stimulating Hormone, which can influence diagnosis, prognosis, and therapeutic decisions.